Source-grounded facts extracted from ILLUMINA, INC.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
ILLUMINA, INC. reported first quarter ended March 29, 2026 results: revenue $1.09 billion, EPS $0.87. Guidance raised.
“Inc. (Nasdaq: ILMN) (“Illumina” or the “company”) today announced its financial results for the first quarter of fiscal year 2026. First quarter 2026 results: • Revenue of $1.09 billion for Q1 2026 , up 4.8% from Q1 2025 (ROW 1 organic revenue growth of 3.5%) • GAAP operating margin of 19.2% and non-GAAP operating margin of 21.9% • GAAP diluted EPS of $0.87 and”
ILLUMINA, INC. completed an acquisition involving Standard BioTools Inc. for $350,000,000 in cash (closed 2026-01-30).
“BioTools’s mass cytometry and microfluidics businesses (the “Business”). On January 30, 2026, the Company completed the Transaction. The Company paid a purchase price of $350,000,000 in cash, subject to customary adjustments. The Purchase Agreement further provides for, in connection with the revenues generated from certain products and services, (i) royalty”
Keith A. Meister was elected as Director at ILLUMINA, INC..
“On March 25, 2025, the Board elected Keith A. Meister to serve on the Board beginning March 28, 2025.”
Stephen P. MacMillan resigned as Director at ILLUMINA, INC..
“On March 25, 2025, Stephen P. MacMillan, notified the Board of Directors (the “Board”) of Illumina, Inc. (the “Company”) of his intention to resign as a director of the Company, effective as of March 28, 2025.”
Carissa Rollins departed as Chief Information Officer at ILLUMINA, INC..
“On March 18, 2025, Carissa Rollins, Chief Information Officer, notified Illumina, Inc. that she will be retiring effective as of April 11, 2025.”
Scott Davies was appointed as Interim General Counsel and Secretary at ILLUMINA, INC..
“As of the Effective Date, Scott Davies, Vice President, Legal – Chief Corporate Counsel and Assistant Secretary, will serve as Interim General Counsel and Secretary.”
Charles Dadswell departed as General Counsel and Secretary at ILLUMINA, INC..
“Charles Dadswell, the Company’s General Counsel and Secretary, will leave Illumina.”
ILLUMINA, INC. announced a impairment with charges of additional right-of-use asset impairments of $18 million in Q1 2024 related to our campus in Foster City, California and another property in San Diego, Californ affecting our campus in Foster City, California and another property in San Diego, California.
“The Company recorded additional right-of-use asset impairments of $18 million in Q1 2024 related to our campus in Foster City, California and another property in San Diego, California. The Company also recorded $14 million of leasehold improvement impairments related to our Foster City campus in Q1 2024.”
ILLUMINA, INC. announced a impairment with charges of $43 million affecting Foster City campus.
“The company recorded right-of-use asset and leasehold improvement impairment charges of $43 million in the fourth fiscal quarter of 2023 related to that exit.”
ILLUMINA, INC. updated its first quarter ended March 31, 2024 guidance (reaffirmed).
“On May 2, 2024, Illumina, Inc. (the "Company") issued a press release announcing financial results for the first quarter ended March 31, 2024.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.